Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q1 EPS of $0.05, $0.14 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $24.3 million versus the consensus estimate of $21.95 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.